A novel hydrogel combining wild blueberry extract and nanocellulose accelerates wound healing by enhancing blood flow and promoting collagen synthesis. Pre-clinical studies show promising results for faster skin regeneration, with future clinical trials planned.
Introducing a groundbreaking wild blueberry extract-nanocellulose hydrogel designed to revolutionize wound healing. This innovative product significantly accelerates wound closure, re-epithelialization, and collagen synthesis, outperforming existing market solutions. By enhancing blood flow and nutrient delivery, it promotes faster skin regeneration, making it ideal for treating burns, cuts, and scrapes.
Key features:
The technology is currently at TRL 5, having successfully demonstrated its potential in pre-clinical animal models. The next steps involve conducting clinical trials to confirm its efficacy in human wound healing applications.
The University of Maine is a comprehensive public research university and the state’s flagship, coupling broad academic depth with an applied, industry‑oriented culture. On campus, companies access large‑scale prototyping facilities, pilot‑scale lines, and specialized test tanks that move concepts toward deployable systems. A statewide Cooperative Extension and field sites connect R&D teams to real‑world conditions across Maine’s coastal, forested, and cold‑weather settings, while industry liaisons streamline sponsored research. Funding comes from competitive federal sources such as the National Science Foundation, Department of Energy, U.S. Department of Agriculture, and the National Oceanic and Atmospheric Administration, while a centralized tech transfer office supports IP, licensing, SBIR/STTR, and startup formation.